Literature DB >> 11018862

Plasma and salivary IgG subclasses in HIV type 1 infection: evidence of both transudation and local synthesis of IgG in parotid saliva.

X Wu1, S Jackson.   

Abstract

In this study we measured the levels of plasma and salivary IgG subclasses in 81 HIV-1-infected individuals and 30 uninfected controls. Salivary IgG1 was increased in HIV-1-infected patients, while salivary IgG2 and IgG4 were decreased. Patients with high levels of plasma anti-HIV-1 IgG antibodies presented a higher CD4+ cell count and lower viral load. High levels of anti-HIV-1 IgG antibodies in plasma were also associated with high levels of anti-HIV-1 IgG antibodies in parotid saliva. In comparing the HIV-1 recognition patterns of salivary IgG with plasma IgG, we determined that plasma and salivary IgG antibodies had similarities as well as differences in their reactivity to HIV-1 antigens. The present study demonstrates that HIV-1 infection affects both plasma and salivary IgG and provides evidence that the origin of HIV-1-specific IgG antibodies in parotid saliva is primarily transudated from plasma; however, some local synthesis of IgG in parotid saliva also occurs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018862     DOI: 10.1089/08892220050140973

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.

Authors:  Diego A Vargas-Inchaustegui; Iskra Tuero; Venkatramanan Mohanram; Thomas Musich; Poonam Pegu; Antonio Valentin; Yongjun Sui; Margherita Rosati; Jenifer Bear; David J Venzon; Viraj Kulkarni; Candido Alicea; Guy R Pilkington; Namal P M Liyanage; Thorsten Demberg; Shari N Gordon; Yichuan Wang; Alison E Hogg; Blake Frey; L Jean Patterson; Janet DiPasquale; David C Montefiori; Niranjan Y Sardesai; Steven G Reed; Jay A Berzofsky; Genoveffa Franchini; Barbara K Felber; George N Pavlakis; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2014-06-04       Impact factor: 3.969

2.  Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals.

Authors:  Xueling Wu; Susan Jackson
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

3.  Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.

Authors:  Meghan K Eberhardt; W L William Chang; Naomi J Logsdon; Yujuan Yue; Mark R Walter; Peter A Barry
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

4.  Quantitative serology for SARS-CoV-2 using self-collected saliva and finger-stick blood.

Authors:  Christopher Campbell; Nikhil Padmanabhan; Daniel Romero; Jessica Joe; Mikias Gebremeskel; Navaratnam Manjula; Noah Wohlstadter; Rachel Wohlstadter; Paul Goodwin; Lillian Quintero; Jeff Debad; George Sigal; Jacob Wohlstadter
Journal:  Sci Rep       Date:  2022-04-21       Impact factor: 4.996

5.  Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis.

Authors:  Berlin Londono-Renteria; Jenny C Cardenas; Andrea Troupin; Tonya M Colpitts
Journal:  Front Immunol       Date:  2016-09-29       Impact factor: 7.561

6.  Saliva-based SARS-CoV-2 serology using at-home collection kits returned via mail.

Authors:  Christopher Campbell; Douglas Roblin; Nikhil Padmanabhan; Daniel Romero; Jessica Joe; Lily Fathi; Thomas Whiting; Jared Williamson; Paul Goodwin; Charmaine Mckie; Adrienne Deneal; Leslie Greenberg; George Sigal
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.